Thu, 21 Mar 2019 18:08:57: Chutes & Ladders—Two senior Genentech executives make the leap to smaller biotechs

Thu, 21 Mar 2019 13:42:56: Forma Therapeutics nabs long-time Genentech commercial executive as CEO

Thu, 21 Mar 2019 13:36:31: Ely Benaim to leave Rexahn, take CMO role at Novocure

Thu, 21 Mar 2019 12:46:29: Alexion strikes Zealand deal to further pipeline rebuild

Thu, 21 Mar 2019 11:54:24: Biogen hit by 'transformative failure' as it cans aducanumab tests

Wed, 20 Mar 2019 22:01:12: Celgene taps Exscientia’s AI drug discovery tech for 3 new programs

Wed, 20 Mar 2019 11:53:55: As Merck boosts R&D pact, NGM Bio gains Genentech, Lilly veteran as new R&D chief

Wed, 20 Mar 2019 11:37:25: Alexion strikes another anti-FcRn deal, bagging Affibody drug

Wed, 20 Mar 2019 11:28:51: Pfizer eyes Fierce 15 winner Vivet buy as gene therapy fever heats up

Wed, 20 Mar 2019 10:55:13: Merck doubles down on NGM Bio pact but culls obesity drug

Wed, 20 Mar 2019 10:42:10: WHO panel pushes for genome editing research registry

Wed, 20 Mar 2019 10:28:51: A liquid biopsy that combines Illumina’s ‘ultradeep’ sequencing with Grail’s machine learning

Tue, 19 Mar 2019 13:35:26: Urovant slips as generic holds its own against overactive bladder drug in phase 3

Tue, 19 Mar 2019 12:48:42: Biogen-Nightstar deal sheds light on gene therapy feeding frenzy

Mon, 18 Mar 2019 13:50:02: Dermira soars as Dupixent challenger hits midphase endpoint

Mon, 18 Mar 2019 13:12:42: Aerpio shares plummet on eye study flop

Mon, 18 Mar 2019 12:21:31: Unlocking a secret of the anti-cancer gene p53

Mon, 18 Mar 2019 11:18:08: Imara lands $63M crossover round to trial sickle cell drug

Mon, 18 Mar 2019 09:50:42: After a hiring blitz, Karuna nabs $68M funding round

Mon, 18 Mar 2019 09:17:40: Allergy Therapeutics’ shares nose-dive as another setback hits the biotech

Fri, 15 Mar 2019 11:39:55: FDA delays Karyopharm PDUFA to review extra information

Fri, 15 Mar 2019 10:55:34: Gottlieb criticizes sponsors’ ‘continued reluctance’ to rethink clinical trials

Thu, 14 Mar 2019 17:01:46: Chutes & Ladders—Novartis' Sandoz chief exits, fueling spinoff and sale rumors

Thu, 14 Mar 2019 13:39:40: C4 poaches new CMO after signing $900M clinical development deal with Roche

Thu, 14 Mar 2019 12:55:41: Esperion shares yo-yo as NEJM papers downplay cancer death data